Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody
- 17 August 2006
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (6) , 694-700
Abstract
Background: Friend leukaemia integration-1 (FLI-1) antibody is a useful marker for Ewing’s sarcoma/primitive neuroectodermal tumour (EWS/PNET) and vascular tumours. However, it is also expressed in subsets of lymphoblastic lymphoma, Merkel cell carcinoma (MCC) and desmoplastic small round cell tumour (DSRCT). Aim: To determine expression of FLI-1 in various benign and malignant neoplasms, by immunohistochemical analysis on 4323 tumours using multiple tumour microarrays, as well as on whole sections. Results: FLI-1 was expressed in 46/62 EWS/PNETs, 2/3 olfactory neuroblastomas, 7/102 small cell carcinomas of the lung, 10/34 MCCs, 1/14 rhabdomyosarcoma, 19/132 non-Hodgkin’s lymphomas, 2/3 DSRCTs, and in 53/74 benign and malignant vascular tumours. In addition, 27/508 squamous cell carcinomas, 19/837 adenocarcinomas, 10/400 urothelial bladder cancers, 1/40 basal cell carcinomas, 3/29 liposarcomas, 1/40 glioblastoma multiforme and 9/29 medullar carcinomas of the breast expressed FLI-1. The sensitivity and specificity of FLI-1 to distinguish EWS/PNET from all types of malignancies were 74.2% and 96.0%, respectively. Finally, the sensitivity and specificity of FLI-1 to distinguish EWS/PNET from other small round cell tumours (SRCTs) were 74.2% and 91.6%, respectively. Conclusion: This study was the first to show that FLI-1 can be seen in a variety of solid tumours, some of which had never been explored before. This finding should be kept in mind, especially when using FLI-1 as a marker for finding the primary origin of poorly differentiated metastatic tumour. Finally, despite the expression of FLI-1 in numerous malignancies, it is still considered to be highly sensitive and specific in distinguishing EWS/PNET from other tumour types in general and from other SRCTs in particular.Keywords
This publication has 19 references indexed in Scilit:
- Ovarian Primary Primitive Neurectodermal Tumor Coexisting With Endometrioid Adenocarcinoma: A Case ReportInternational Journal of Gynecological Pathology, 2006
- Undifferentiated Intimal Sarcoma of Large Systemic Blood VesselsAmerican Journal of Surgical Pathology, 2005
- Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.2005
- Hepatocyte Paraffin 1 Expression in Human Normal and Neoplastic Tissues: Tissue Microarray Analysis on 3,940 Tissue SamplesAmerican Journal of Clinical Pathology, 2004
- Frequent EpCam protein expression in human carcinomasHuman Pathology, 2004
- Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samplesHuman Pathology, 2003
- Primary Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the KidneyAmerican Journal of Surgical Pathology, 2002
- Biology of EWS/ETS fusions in Ewing's family tumorsOncogene, 2001
- Immunohistochemical Detection of EWS and FLI-1 Proteins in Ewing Sarcoma and Primitive Neuroectodermal Tumors: Comparative Analysis With CD99 (MIC-2) ExpressionApplied Immunohistochemistry & Molecular Morphology, 2001
- The avian fli gene is specifically expressed during embryogenesis in a subset of neural crest cells giving rise to mesenchymeThe International Journal of Developmental Biology, 1998